CureVac N.V. (NASDAQ:CVAC)
|Dividend Rate (ttm)||0.0000|
|Trading Day||Mar 24|
|Day's Range||6.33 - 6.58|
|52 Week Range||5.63 - 20.45|
About CureVac N.V.
CureVac N.V. operates as a global clinical-stage biopharmaceutical company.
The Company focuses on developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. CureVac serves customers worldwide.
CureVac N.V. dividends
CureVac N.V. has a market cap or net worth of $1.43 billion. The enterprise value is $0.
CureVac N.V. has 221.98 million shares outstanding.
The trailing PE ratio is 0.0000 and the forward PE ratio is -5.7852. CureVac N.V.'s PEG ratio is 0.0000.
Stock Price Statistics
The stock price has increased by 0.0829%. The beta is 1.2394, so CureVac N.V.'s price volatility has been higher than the market average.
In the last 12 months, CureVac N.V. had revenue of $0 and earned $0 in profits. Earnings per share was $.